April 12, 2022
Prestigious award named in honor of Valentin Fuster, MD, Ph.D., during ACC.22
April 12, 2022 – The American College of Cardiology (ACC) is establishing a new award in honor of Valentin Fuster, MD,…
Read More
WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device
April 12, 2022
Leaks After Left Atrial Appendage Occlusion Heighten Stroke Risk
April 12, 2022 –  Patients who had leakage to the left atrial appendage due to incomplete device sealing after left…
Read More
April 12, 2022
Late-breaking Data at ACC.22 with Over 1 Million Patients Demonstrates a Major Gap in Guideline Adherence Resulting in Higher Mortality for Patients with Infected CIEDs
Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world…
Read More
Man clutching heart
April 12, 2022
Two-Year Data from International COVID-19 STEMI Research Reveals Mortality is Decreasing for COVID-19 Patients with Heart Attacks but Remains High for Unvaccinated Patients
April 12, 2022 – The Minneapolis Heart Institute Foundation (MHIF) has announced the first presentation and…
Read More
atrial fibrillation
April 12, 2022
Zio by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
April 12, 2022 –  iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement…
Read More
The American College of Cardiology has issued an expert consensus decision pathway for the evaluation and management of adults with key cardiovascular consequences of COVID-19.
April 12, 2022
ACC Issues Clinical Guidance on Cardiovascular Consequences of COVID-19
April 12, 2022 — The American College of Cardiology has issued an expert consensus decision pathway for the evaluation…
Read More
Fitbit received clearance from the U.S. Food and Drug Administration for our new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib). The algorithm will power our new Irregular Heart Rhythm Notifications feature on Fitbit.
April 12, 2022
New Fitbit Feature Makes AFib Detection More Accessible
April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG (…
Read More
Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute at Cedars-Sinai and the Mark S. Siegel Family Foundation Distinguished Professor
April 12, 2022
Cell-Derived Therapy May Help Repair Abnormal Heart Rhythm
April 12, 2022 — Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm…
Read More
 Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include coronary use.
April 12, 2022
FDA Clears Four New Coronary Micro Support Catheters
April 12, 2022 — Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include…
Read More
Radiation to the heart during treatment for locally advanced lung cancer is associated with an increased risk of major adverse cardiac events within the first two years following treatment. The higher the cardiac dose exposure, the higher the risk of a cardiac event.
April 11, 2022
Simple Changes in Care Reduced Heart Exposure During Lung Cancer Radiation Treatment
April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an…
Read More
Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after seeing a patient, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
April 08, 2022
Electronic Alert Improves Guideline Adherence for Heart Failure Treatment
April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they…
Read More
Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
April 08, 2022
Patiromer Helps Patients Stay on Optimal Heart Failure Therapy
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure…
Read More
Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.
April 08, 2022
Rate of Structural Valve Deterioration Lower with TAVR than with SAVR
April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less…
Read More
The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.
April 07, 2022
ACC Program sees Improvement in Global Heart Attack Care
April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports…
Read More
ADAPT-TAVR Trial
April 07, 2022
No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR
April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement…
Read More
Tricuspid valve
April 07, 2022
Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up
April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who…
Read More
Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery.
April 07, 2022
Blood Pressure Management Strategy During Surgery Has No Impact on Major Cardiovascular Complications
April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a…
Read More
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or “bad” cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk.
April 06, 2022
SLN360 Markedly Reduces Lipoprotein(a), an Important Cause of Heart Disease
April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density…
Read More
Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).
April 06, 2022
Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis…
Read More
Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.
April 06, 2022
In-Hospital Deaths in STEMI Patients With COVID-19 Drop in 2021
April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now